These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8525684)
1. Immune responses induced by administration of encapsidated poliovirus replicons which express HIV-1 gag and envelope proteins. Moldoveanu Z; Porter DC; Lu A; McPherson S; Morrow CD Vaccine; 1995 Aug; 13(11):1013-22. PubMed ID: 8525684 [TBL] [Abstract][Full Text] [Related]
2. Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans. Porter DC; Ansardi DC; Morrow CD J Virol; 1995 Mar; 69(3):1548-55. PubMed ID: 7853488 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins. Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427 [TBL] [Abstract][Full Text] [Related]
4. Encapsidation of genetically engineered poliovirus minireplicons which express human immunodeficiency virus type 1 Gag and Pol proteins upon infection. Porter DC; Ansardi DC; Choi WS; Morrow CD J Virol; 1993 Jul; 67(7):3712-9. PubMed ID: 8389902 [TBL] [Abstract][Full Text] [Related]
5. Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response. Novak MJ; Smythies LE; McPherson SA; Smith PD; Morrow CD Vaccine; 1999 May; 17(19):2384-91. PubMed ID: 10392620 [TBL] [Abstract][Full Text] [Related]
6. Encapsidation and serial passage of a poliovirus replicon which expresses an inactive 2A proteinase. Ansardi DC; Pal-Ghosh R; Porter D; Morrow CD J Virol; 1995 Feb; 69(2):1359-66. PubMed ID: 7815522 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease. Fultz PN; Stallworth J; Porter D; Novak M; Anderson MJ; Morrow CD Virology; 2003 Oct; 315(2):425-37. PubMed ID: 14585346 [TBL] [Abstract][Full Text] [Related]
8. Immunization of mice with poliovirus replicons expressing the C-fragment of tetanus toxin protects against lethal challenge with tetanus toxin. Porter DC; Wang J; Moldoveanu Z; McPherson S; Morrow CD Vaccine; 1997 Feb; 15(3):257-64. PubMed ID: 9139483 [TBL] [Abstract][Full Text] [Related]
9. Inherent instability of poliovirus genomes containing two internal ribosome entry site (IRES) elements supports a role for the IRES in encapsidation. Johansen LK; Morrow CD J Virol; 2000 Sep; 74(18):8335-42. PubMed ID: 10954532 [TBL] [Abstract][Full Text] [Related]
10. Release of virus-like particles from cells infected with poliovirus replicons which express human immunodeficiency virus type 1 Gag. Porter DC; Melsen LR; Compans RW; Morrow CD J Virol; 1996 Apr; 70(4):2643-9. PubMed ID: 8642700 [TBL] [Abstract][Full Text] [Related]
11. Demonstration of the specificity of poliovirus encapsidation using a novel replicon which encodes enzymatically active firefly luciferase. Porter DC; Ansardi DC; Wang J; McPherson S; Moldoveanu Z; Morrow CD Virology; 1998 Mar; 243(1):1-11. PubMed ID: 9527910 [TBL] [Abstract][Full Text] [Related]
12. Poliovirus replicons that express the gag or the envelope surface protein of simian immunodeficiency virus SIV(smm) PBj14. Anderson MJ; Porter DC; Fultz PN; Morrow CD Virology; 1996 May; 219(1):140-9. PubMed ID: 8623523 [TBL] [Abstract][Full Text] [Related]
13. The RNA encompassing the internal ribosome entry site in the poliovirus 5' nontranslated region enhances the encapsidation of genomic RNA. Johansen LK; Morrow CD Virology; 2000 Aug; 273(2):391-9. PubMed ID: 10915610 [TBL] [Abstract][Full Text] [Related]
15. Targeted foreign gene expression in spinal cord neurons using poliovirus replicons. Bledsoe AW; Gillespie GY; Morrow CD J Neurovirol; 2000 Apr; 6(2):95-105. PubMed ID: 10822323 [TBL] [Abstract][Full Text] [Related]
16. Intramuscular immunization with poliovirus replicons primes for a humoral and cellular immune response to soluble antigen. Novak MJ; Moldoveanu Z; Huang WQ; Jackson CA; Palmer MT; McPherson SA; Morrow CD Viral Immunol; 2003; 16(2):169-82. PubMed ID: 12828868 [TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of encapsidated poliovirus replicons that express biologically active murine interleukin-2. Basak S; McPherson S; Kang S; Collawn JF; Morrow CD J Interferon Cytokine Res; 1998 May; 18(5):305-13. PubMed ID: 9620357 [TBL] [Abstract][Full Text] [Related]
18. Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. Ansardi DC; Porter DC; Morrow CD J Virol; 1993 Jun; 67(6):3684-90. PubMed ID: 8388519 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397 [TBL] [Abstract][Full Text] [Related]
20. Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env. Collado M; Rodríguez D; Rodríguez JR; Vázquez I; Gonzalo RM; Esteban M Vaccine; 2000 Jul; 18(27):3123-33. PubMed ID: 10856792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]